The efficacy of ERT is typically measured by monitoring the levels of the accumulated substrate in the patient's tissues and bodily fluids. Clinical outcomes, such as improvements in organ function, growth, and quality of life, are also important indicators of treatment success. Biomarkers are often used to assess the biochemical impact of ERT and guide dosage adjustments.
